OPER TECHNOLOGY LIMITED is to develop and perfect an innovative technology in nanomaterial-based personalized medicine that can offer an inexpensive, real-time monitoring, precise, effective and globally available medical technology, to improve the healthcare and clinical practices for restoring health and extending life of patients with incurable diseases.

This new core technology is a nanosurgery with real-time monitoring that enables both specific cell harvest in complicated systems in the body, cell engineering and specific drug delivery to specific cells in the body.

The target groups that can be benefited from our technology are

1) patients with neurological diseases;

2) patients with other incurable diseases that can be treated with our nanosurgery such as patients with cancers;

3) research laboratories and medical research institutes around the world.

We are also committed to advancing the medical technology and inspiring researchers with the innovative medical technology solutions.